Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5186863
Max Phase: Preclinical
Molecular Formula: C30H47NO8
Molecular Weight: 549.71
Associated Items:
ID: ALA5186863
Max Phase: Preclinical
Molecular Formula: C30H47NO8
Molecular Weight: 549.71
Associated Items:
Canonical SMILES: CC(=O)O[C@@H](C)/C=C\C(=O)N[C@@H]1C[C@H](C)[C@H](C/C=C(C)/C=C/[C@H]2O[C@H](CC(C)(C)O)C[C@@]3(CO3)[C@@H]2O)O[C@@H]1C
Standard InChI: InChI=1S/C30H47NO8/c1-18(9-12-26-28(34)30(17-36-30)16-23(39-26)15-29(6,7)35)8-11-25-19(2)14-24(21(4)38-25)31-27(33)13-10-20(3)37-22(5)32/h8-10,12-13,19-21,23-26,28,34-35H,11,14-17H2,1-7H3,(H,31,33)/b12-9+,13-10-,18-8+/t19-,20-,21+,23+,24+,25-,26+,28+,30+/m0/s1
Standard InChI Key: YDDGOVRUVVWGJP-JXAFQLEPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 549.71 | Molecular Weight (Monoisotopic): 549.3302 | AlogP: 3.13 | #Rotatable Bonds: 10 |
Polar Surface Area: 126.85 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.91 | CX Basic pKa: | CX LogP: 1.92 | CX LogD: 1.92 |
Aromatic Rings: 0 | Heavy Atoms: 39 | QED Weighted: 0.16 | Np Likeness Score: 2.58 |
1. Ghosh AK, Mishevich JL, Jurica MS.. (2021) Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors., 84 (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100] |
Source(1):